Experimental effects of Saccharomyces boulardii on diarrheal pathogens

Microbes and Infection

Volumn 4, Issue 7, 2002, Pages 733-739

  Czerucka, Dorota ^a   Rampal, Patrick ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Biotherapeutic agent; Clostridium difficile associated intestinal disease; Infectious diarrhea; Probiotic therapy; Saccharomyces boulardii

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CLINDAMYCIN; FUNGAL PROTEIN; PROTEINASE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROCOLITIS; HUMAN; INTESTINE INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES BOULARDII; VIBRIO CHOLERAE;

ANIMALS; CHOLERA; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; PROBIOTICS; SACCHAROMYCES; VIBRIO CHOLERAE;

ANIMALIA; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; SACCHAROMYCES; SACCHAROMYCES BOULARDII;

EID: 0036286070     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01592-7     Document Type: Review

References (39)

1. Probiotics in human medicine
2. Protection from gastrointestinal diseases with the use of probiotics
3. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections
4. Biotherapeutic agents in the treatment of infectious diarrhea
5. Electrophoretic karyotypes of authentic strains of the sensu stricto group of the genus Saccharomyces
6. Genotypic study of Saccharomyces boulardii compared to the Saccharomyces sensu stricto complex species
7. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains
8. Disposition kinetics of Saccharomyces boulardii in man and rat
9. Impact écologique de l'antibiothérapie. Place des microorganismes de substitution dans le contrôle des diarrhées et colites associées aux antibiotiques
10. Micro-organisms administered in the benefit of the host: Myths and facts
11. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
12. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii
13. Possible role of catheters in Saccharomyces boulardii fungemia
14. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with Ultra-Levura
15. Microbes and microbial toxins: Paradigms for microbial interactions II. The integrated response of the intestine to Clostridium difficile toxins
16. Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii
17. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii
18. Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventive agent in gnotobiotic mice
19. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: A scanning electron microscopic and microbiological study
20. Réponse aux toxines A et B de Clostridium difficile d'une lignée de cellules épithéliales intestinales de rat IRD98. Effet de Saccharomyces boulardii
21. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
22. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
23. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxin A and B in human colonic mucosa
24. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice
25. Protective effect of Saccharomyces boulardii against the cholera toxin in rats
26. Vibrio cholerae O1
27. Influence de Saccharomyces boulardii, sur la sécrétion jéjunale induite chez le rat par la toxine cholérique
28. Antidiarrheal action of the yeast Saccharomyces boulardii in the rat small and large intestine by stimulating chloride absorption
29. Effet de Saccharomyces boulardii sur le taux d'AMPc induit par la toxine cholérique dans les cellules épithéliales intestinales de rat en culture
30. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3'5'-cyclic monophosphate induction in intestinal cells
31. - secretion in T84 cells
32. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae
33. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexeneri in conventional and gnotobiotic mice
34. Enteropathogenic and enterohaemorrhagic Escherichia coli: More subsertive elements
35. Infection of T84 cells enteropathogenic Escherichia coli alters barrier and transport functions
36. Saccharomyces boulardii preserves the barrier function and modulates the transduction pathway induced in Enteropathogenic Escherichia coli-infected T84 cells
37. Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated proteine kinase pathway
38. Response of human and rat intestinal mucosa to oral administration of Saccharomyces boulardii
39. Stimulation of secretory Ig A and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii